Gene · 2767
Papers2,923
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,923
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulation of the Hippo/YAP axis by CXCR7 in the tumorigenesis of gastric cancer. | J Exp Clin Cancer Res | 2023 | 37950281 | PubTator, text mining | PubMed |
| Preliminary results of the European multicentric phase III trial regarding sirolimus in slow-flow vascular malformations. | JCI Insight | 2023 | 37937645 | PubTator, text mining | PubMed |
| Kinome profiling identifies MARK3 and STK10 as potential therapeutic targets in uveal melanoma. | J Biol Chem | 2023 | 37923138 | PubTator, text mining | PubMed |
| Severe Hypercalcemia Due to Primary Hyperparathyroidism and Heterozygous Pathogenic Variant of CYP24A1. | JCEM Case Rep | 2023 | 37909006 | PubTator, text mining | PubMed |
| Decreased eukaryotic initiation factors expression upon temozolomide treatment-potential novel implications for eIFs in glioma therapy. | J Neurooncol | 2023 | 37907716 | PubTator, text mining | PubMed |
| Pediatric Neuroendocrine Neoplasia of the Parathyroid Glands: Delving into Primary Hyperparathyroidism. | Biomedicines | 2023 | 37893182 | PubTator, text mining | PubMed |
| Patient Derived Xenografts (PDX) Models as an Avatar to Assess Personalized Therapy Options in Uveal Melanoma: A Feasibility Study. | Curr Oncol | 2023 | 37887557 | PubTator, text mining | PubMed |
| Next-Generation Sequencing Analysis of Mutations in Circulating Tumor DNA from the Plasma of Patients with Head-Neck Cancer Undergoing Chemo-Radiotherapy Using a Pan-Cancer Cell-Free Assay. | Curr Oncol | 2023 | 37887543 | PubTator, text mining | PubMed |
| Transcriptome analysis reveals molecular mechanisms of lymphocystis formation caused by lymphocystis disease virus infection in flounder (Paralichthys olivaceus). | Front Immunol | 2023 | 37868974 | PubTator, text mining | PubMed |
| Release of Cell-Free Tumor DNA in the Plasma of Uveal Melanoma Patients Under Radiotherapy. | Invest Ophthalmol Vis Sci | 2023 | 37862025 | PubTator, text mining | PubMed |
| High-throughput chemogenetic drug screening reveals PKC-RhoA/PKN as a targetable signaling vulnerability in GNAQ-driven uveal melanoma. | Cell Rep Med | 2023 | 37858338 | PubTator, text mining | PubMed |
| β-Arrestin-dependent and -independent endosomal G protein activation by the vasopressin type 2 receptor. | Elife | 2023 | 37855711 | PubTator, text mining | PubMed |
| Deep molecular tracking over the 12-yr development of endometrial cancer from hyperplasia in a single patient. | Cold Spring Harb Mol Case Stud | 2023 | 37848227 | PubTator, text mining | PubMed |
| Next-generation sequencing in dermatology. | Front Med (Lausanne) | 2023 | 37841001 | PubTator, text mining | PubMed |
| Umbilical Cord Diseases Affecting Obstetric and Perinatal Outcomes. | Healthcare (Basel) | 2023 | 37830671 | PubTator, text mining | PubMed |
| PAK1 and Therapy Resistance in Melanoma. | Cells | 2023 | 37830586 | PubTator, text mining | PubMed |
| Lateral heat flux reduction using a lock-in thermography compensation method. | Sci Rep | 2023 | 37816782 | PubTator, text mining | PubMed |
| GLP-1R signaling neighborhoods associate with the susceptibility to adverse drug reactions of incretin mimetics. | Nat Commun | 2023 | 37813859 | PubTator, text mining | PubMed |
| Late-Onset Status Epilepticus Associated With Isolated Leptomeningeal Angioma and Sturge-Weber Syndrome-Related GNA11 Pathogenic Variation. | Neurology | 2023 | 37813580 | PubTator, text mining | PubMed |
| Brazilian Society of Otology task force - Vestibular Schwannoma ‒ evaluation and treatment. | Braz J Otorhinolaryngol | 2023 | 37813009 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2767/papers?page=13